Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Contrave
Contrave
Orexigen rises after obesity drug doesn't increase heart risk in study
The Fly on the Wall
Mon, 11/25/13 - 11:45 am
Orexigen
obesity
Contrave
Orexigen Weight-Loss Pill Passes Safety Hurdle
TheStreet.com
Mon, 11/25/13 - 10:35 am
Orexigen
obesity
Contrave
FDA
Takeda
Can Orexigen Therapeutics Catch Up With Arena Pharmaceuticals and VIVUS?
Motley Fool
Mon, 11/11/13 - 10:19 am
Arena Pharmaceuticals
Vivus
obesity
Orexigen
Contrave
Belviq
Qsymia
Sanofi To Manufacture Orexigen’s Contrave
Contract Pharma
Fri, 11/8/13 - 09:36 am
Sanofi
drug manufacturing
Contrave
Orexigen
[video]Can This Obesity-Drug Maker Beat Arena and VIVUS in Europe?
Motley Fool
Mon, 10/7/13 - 09:12 am
obesity
Europe
Vivus
Arena Pharmaceuticals
Belviq
Qsymia
Contrave
Orexigen
Orexigen obesity drug Contrave filed in Europe
Pharma Times, UK
Fri, 10/4/13 - 10:16 am
Orexigen
Europe
Contrave
obesity
Obesity drug makers jockey for position as analysts praise Vivus
Marketwatch
Thu, 10/3/13 - 05:29 pm
obesity
Vivus
Belviq
Arena Pharmaceuticals
Contrave
Orexigen
Qsymia
Third Obesity Drug Moves Closer to FDA Approval
Motley Fool
Thu, 08/29/13 - 05:05 pm
obesity
FDA
Orexigen
Contrave
Belviq
Qsymia
Vivus
Arena Pharmaceuticals
Orexigen Readies New Drug Application
Seeking Alpha
Tue, 08/27/13 - 10:56 am
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Belviq
Qsymia
Vivus
Who Will Be the Winner in the Fight Against Obesity?
Motley Fool
Thu, 08/22/13 - 05:37 pm
obesity
Vivus
Qsymia
Belviq
Eisai
Arena Pharmaceuticals
Contrave
Orexigen
Arena Approaches 50% Institutional Ownership
Seeking Alpha
Thu, 08/15/13 - 02:53 pm
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
Contrave
Qsymia
The Obesity Drug Battle
Seeking Alpha
Wed, 07/10/13 - 01:56 pm
obesity
Belviq
Arena Pharmaceuticals
Contrave
Orexigen
Vivus
Qsymia
Roche
Xenical
GSK
The Hidden Way to Invest in Obesity
Motley Fool
Sun, 06/30/13 - 10:40 am
Orexigen
obesity
weight loss
Contrave
Is The Anti-Obesity Space Going To Get Crowded?
Seeking Alpha
Mon, 06/24/13 - 10:52 am
obesity
Arena Pharmaceuticals
Orexigen
Vivus
beloranib
Zagfen
Contrave
Belviq
Qsymia
Obesity Sector Gets New Shoes
Seeking Alpha
Thu, 06/20/13 - 07:48 am
obesity
Arena Pharmaceuticals
Vivus
Orexigen
Contrave
Belviq
Qsymia
2 Biotech Approval Outcomes That Might Affect You
Motley Fool
Wed, 06/19/13 - 11:08 am
drug approvals
Afrezza
MannKind
Contrave
Orexigen
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
3 Pipeline Obesity Treatments You Should Watch
Motley Fool
Thu, 05/23/13 - 12:03 pm
obesity
Vivus
Orexigen
Contrave
Belviq
tesofensine
Neurosearch
Qsymia
Arena Pharmaceuticals
Will Obesity Drugs Gain Soon?
Motley Fool
Wed, 05/15/13 - 09:50 am
obesity
Novo Nordisk
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
Contrave
Qsymia
Victoza
How Doctors Actually Diagnose Obesity
Motley Fool
Sun, 04/7/13 - 10:41 am
obesity
weight loss
Vivus
Arena Pharmaceuticals
Orexigen
Belviq
Qsymia
Contrave
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »